secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immuneering Corp (IMRX)
CIK:        0001790340
Form:       8-K
Filed at:   2026-11-09T21:16:03+00:00
Accession:  0001790340-26-000099
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4.1-flash:cloud@v2

Immuneering adds Grant C. Bogle to board as Class III director effective Nov 9, 2026
--------------------------------------------------------------------------------

- Board of Immuneering Corporation appointed Grant C. Bogle, MBA, as a Class III director on November 9, 2026.
- Bogle has not been appointed to any board committee at this time.
- Bogle will be compensated per the company's standard non-employee director arrangements and signed the standard director/officer indemnification agreement.
- No arrangement or understanding existed pursuant to which Bogle was elected as a director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1790340/000179034026000099/0001790340-26-000099-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1790340/000179034026000099/imrx-20261109.htm
  HTML page:      https://secwatch.observer/filing/0001790340-26-000099

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer